Bristlecone Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $221K | Hold |
|
|||||
|
2025
Q2 | $209K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $206K | Sell |
|
|||||
|
2024
Q2 | $293K | Hold |
|
|||||
|
2024
Q1 | $266K | Hold |
|
|||||
|
2023
Q4 | $278K | Hold |
|
|||||
|
2023
Q3 | $281K | Hold |
|
|||||
|
2023
Q2 | $278K | Hold |
|
|||||
|
2023
Q1 | $253K | Sell |
|
|||||
|
2022
Q4 | $251K | Hold |
|
|||||
|
2022
Q3 | $210K | Hold |
|
|||||
|
2022
Q2 | $234K | Hold |
|
|||||
|
2022
Q1 | $242K | Hold |
|
|||||
|
2021
Q4 | $242K | Hold |
|
|||||
|
2021
Q3 | $226K | Hold |
|
|||||
|
2021
Q2 | $252K | Sell |
|
|||||
|
2021
Q1 | $1.83M | Sell |
|
|||||
|
2020
Q4 | $2.3M | Buy |
|
|||||
|
2020
Q3 | $2.11M | Sell |
|
|||||
|
2020
Q2 | $2.78M | Sell |
|
|||||
|
2020
Q1 | $2.63M | Sell |
|
|||||
|
2019
Q4 | $3.09M | Buy |
|
|||||
|
2019
Q3 | $2.73M | Sell |
|
|||||
|
2019
Q2 | $2.94M | Sell |
|
|||||
|
2019
Q1 | $3.25M | Buy |
|
|||||
|
2018
Q4 | $2.86M | Sell |
|
|||||
|
2018
Q3 | $2.89M | Buy |
|
|||||
|
2018
Q2 | $1.44M | Sell |
|
|||||
|
2018
Q1 | $1.77M | Sell |
|
|||||
|
2017
Q4 | $2.6M | Buy |
|
|||||
|
2017
Q3 | $2.65M | Buy |
|
|||||
|
2017
Q2 | $2.54M | Buy |
|
|||||
|
2017
Q1 | $2.22M | Buy |
|
|||||
|
2016
Q4 | $2.04M | Sell |
|
|||||
|
2016
Q3 | $2.36M | Sell |
|
|||||
|
2016
Q2 | $2.48M | Buy |
|
|||||
|
2016
Q1 | $1.95M | Buy |
|
|||||
|
2015
Q4 | $2.08M | Buy |
|